Deferasirox Glenmark

Deferasirox Glenmark is an oral medication used to manage iron overload. This pharmaceutical helps reduce excess iron in the body, often prescribed for conditions like thalassemia.

Deferasirox Glenmark is primarily used to treat iron overload in patients receiving frequent blood transfusions. It helps to chelate excess iron, preventing potential complications. This medication is often prescribed for conditions such as thalassemia, where iron accumulation is a concern. Deferasirox works by binding to iron and facilitating its excretion from the body.

Common effects of Deferasirox Glenmark may include gastrointestinal issues like nausea, vomiting, and diarrhea. Some users might experience skin rashes or changes in vision. It is important to monitor for any adverse reactions and consult a healthcare provider if severe side effects occur.

Deferasirox Glenmark should be used with caution in patients with liver or kidney problems. Regular monitoring of liver function and kidney function is recommended. It is important to follow the prescribed dosage and administration instructions to minimize potential risks.

Deferasirox Glenmark may interact with certain medications, including CYP inhibitors and other drugs that affect liver enzymes. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be moderated while using this medication.